A Randomized, Placebo-Controlled, Double-Masked Clinical Trial of Buspirone in the Treatment of 2- 6 Year Old Children With Autistic Disorder
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Buspirone (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- Acronyms B-ACE
Most Recent Events
- 26 Jul 2016 Biomarkers information updated
- 05 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 May 2012 Planned end date changed from 1 Jan 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.